Episode Details

Back to Episodes
Ep 25: Phase 1 trial uses base editing to safely lower LDL cholesterol in familial hypercholesterolemia patients.

Ep 25: Phase 1 trial uses base editing to safely lower LDL cholesterol in familial hypercholesterolemia patients.

Season 1 Episode 25 Published 3Β months, 1Β week ago
Description
# Planetterrian Daily **Date:** March 03, 2026 🌍 **Planetterrian Daily** - Science, Longevity & Health Discoveries **HOOK:** Phase 1 trial uses base editing to safely lower LDL cholesterol in familial hypercholesterolemia patients. ━━━━━━━━━━━━━━━━━━━━ ### Top 15 Science & Health Discoveries 1. **Base editing advances for familial hypercholesterolemia** : 03 March 2026 β€’ Nature A phase 1 study showed liver-targeted PCSK9 base editing as proof-of-concept for treating familial hypercholesterolemia. Optimization of efficiency, safety, and trial design is needed to make it transformative. Source: https://www.nature.com/articles/s41591-026-04220-0 2. **US federal funding shifts in fetal tissue research** : 03 March 2026 β€’ Nature An analysis traces the rise and decline of US federally funded human fetal tissue research. This highlights policy impacts on scientific progress in medical fields. Source: https://www.nature.com/articles/s41591-026-04268-y 3. **Gene therapy trial for high cholesterol condition** : 03 March 2026 β€’ Nature Six patients with heterozygous familial hypercholesterolemia received lipid nanoparticles for PCSK9 base editing, reducing LDL levels without serious adverse events. It provides early evidence for in vivo gene editing as a potential one-time treatment. Source: https://www.nature.com/articles/s41591-026-04254-4 4. **Global antimicrobial resistance governance evaluation** : 03 March 2026 β€’ Nature A review of 193 countries found strong multisectoral governance and surveillance linked to sustained reductions in antimicrobial resistance. This informs updates to the 2026 Global Action Plan for better worldwide strategies. Source: https://www.nature.com/articles/s41591-026-04257-1 5. **LLM review in clinical medicine studies** : 03 March 2026 β€’ Nature An LLM-assisted systematic review of over 1,000 studies showed most lack real-world clinical data despite growth in medical AI research. It underscores the need for more applied testing to validate LLMs in healthcare. Source: https://www.nature.com/articles/s41591-026-04229-5 6. **Equitable distribution in global climate research** : 03 March 2026 β€’ Nature An opinion piece argues for sharing risks and responsibilities in climate research alongside its global nature. This could lead to fairer collaboration and broader impact on environmental challenges. Source: https://www.nature.com/articles/d41586-026-00680-z 7. **Digital gut simulations predict probiotic success** : 02 March 2026 β€’ Science News A digital model of the gut forecasted which probiotics and fiber diets would establish in microbiomes for better health outcomes. It offers a tool for personalized nutrition to enhance gut health. Source: https://www.sciencenews.org/article/probiotics-gut-simulations-microbiome 8. **Accelerated aging in young cancer survivors** : 02 March 2026 β€’ Science Daily Young cancer survivors exhibit faster biological aging, especially from chemotherapy, leading to cognitive issues like memory problems. Lifestyle interventions such as exercise may mitigate these effects on long-term well-being. Source: https://www.sciencedaily.com/releases/2026/03/260302030652.htm 9. **February 2026 rejuvenation research highlights** : 02 March 2026 β€’ Lifespan.io The roundup covers key advancements in rejuvenation research, including interviews with researchers on recent work. It points to ongoing progress in extending healthy lifespans through targeted therapies. Source: https://lifespan.io/news/rejuvenation-roundup-february-2026/?utm_source=rss&utm_medium=rss&utm_campaign=rejuvenation-roundup-february-2026 10. **New therapy approach for type 1 diabetes** : 02 March 2026 β€’ Science Daily Researchers developed lab-made insulin cells protected by engineered immune cells to avoid rejection without drugs. This could provide a durable treatment for long-term diabetes patients. Source: https://www.sciencedaily.com/releases/2026/03/2603020...
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us